These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 23208423)

  • 1. Recapitulation of spinal motor neuron-specific disease phenotypes in a human cell model of spinal muscular atrophy.
    Wang ZB; Zhang X; Li XJ
    Cell Res; 2013 Mar; 23(3):378-93. PubMed ID: 23208423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
    Martinez TL; Kong L; Wang X; Osborne MA; Crowder ME; Van Meerbeke JP; Xu X; Davis C; Wooley J; Goldhamer DJ; Lutz CM; Rich MM; Sumner CJ
    J Neurosci; 2012 Jun; 32(25):8703-15. PubMed ID: 22723710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
    Xu CC; Denton KR; Wang ZB; Zhang X; Li XJ
    Dis Model Mech; 2016 Jan; 9(1):39-49. PubMed ID: 26586529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
    Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
    Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective.
    Blatnik AJ; McGovern VL; Burghes AHM
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.
    Anderton RS; Meloni BP; Mastaglia FL; Boulos S
    Mol Neurobiol; 2013 Apr; 47(2):821-32. PubMed ID: 23315303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic assessment of a cell model of spinal muscular atrophy.
    Wu CY; Whye D; Glazewski L; Choe L; Kerr D; Lee KH; Mason RW; Wang W
    BMC Neurosci; 2011 Mar; 12():25. PubMed ID: 21385431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for SMN exon 7 splicing in the selective vulnerability of motor neurons in spinal muscular atrophy.
    Ruggiu M; McGovern VL; Lotti F; Saieva L; Li DK; Kariya S; Monani UR; Burghes AH; Pellizzoni L
    Mol Cell Biol; 2012 Jan; 32(1):126-38. PubMed ID: 22037760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
    Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
    Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
    Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
    Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal Muscle Atrophy.
    Lomonte P; Baklouti F; Binda O
    Biochemistry; 2020 Apr; 59(14):1391-1397. PubMed ID: 32227847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
    J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
    Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
    Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
    d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
    Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The water extract of Liuwei dihuang possesses multi-protective properties on neurons and muscle tissue against deficiency of survival motor neuron protein.
    Tseng YT; Jong YJ; Liang WF; Chang FR; Lo YC
    Phytomedicine; 2017 Oct; 34():97-105. PubMed ID: 28899515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.
    Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L
    Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.
    Mutsaers CA; Wishart TM; Lamont DJ; Riessland M; Schreml J; Comley LH; Murray LM; Parson SH; Lochmüller H; Wirth B; Talbot K; Gillingwater TH
    Hum Mol Genet; 2011 Nov; 20(22):4334-44. PubMed ID: 21840928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes.
    Rodriguez-Muela N; Parkhitko A; Grass T; Gibbs RM; Norabuena EM; Perrimon N; Singh R; Rubin LL
    J Clin Invest; 2018 Jul; 128(7):3008-3023. PubMed ID: 29672276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.